Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vose

Showing results (61-70 of 891) with videos related to

Pageof 90
Sort By:
Evolutionary Computation|January 1, 1997
General cardinality genetic algorithmsKoehler, Bhattacharyya, Vose
Archiv Fur Geschwulstforschung|January 1, 1981
Expansion of autorecognitive cytotoxic effectors in human cancer by T cell growth factor (Interleukin 2)1B M Vose
Oncology (Williston Park, N.Y.)|March 17, 2001
Immunotherapy for non-Hodgkin's lymphomaJ M Vose
The Public Health Laboratory|February 19, 2014
Cardiolipin versus regular antigens in 1949 federal evaluation of serodiagnostic tests for syphilisL O VOSE
Revue Scientifique Et Technique (International Office of Epizootics)|April 1, 1997
Risk analysis in relation to the importation and exportation of animal productsD J Vose
Cancer Immunology, Immunotherapy : CII|January 1, 1984
Activation of lymphocyte anti-tumor responses in man. Towards an understanding of effector cell heterogeneity?B M Vose
Leukemia & Lymphoma|January 1, 1995
CHLVPP therapy for Hodgkin's disease identification of prognostic factorsJ M Vose
Hematology/Oncology Clinics of North America|October 29, 2008
Peripheral T-cell non-Hodgkin's lymphomaJulie M Vose
Investigative Radiology|May 1, 1971
Bone mineral measurement: a question of the reliability of in vitro studiesG P Vose
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2011
Relapsed diffuse large B-cell lymphoma: clinical utility of cell of originJulie M Vose
Pageof 90

Showing results (61-70 of 891) with videos related to

Sort By:
Pageof 90
Evolutionary Computation|January 1, 1997
General cardinality genetic algorithmsKoehler, Bhattacharyya, Vose
Archiv Fur Geschwulstforschung|January 1, 1981
Expansion of autorecognitive cytotoxic effectors in human cancer by T cell growth factor (Interleukin 2)1B M Vose
Oncology (Williston Park, N.Y.)|March 17, 2001
Immunotherapy for non-Hodgkin's lymphomaJ M Vose
The Public Health Laboratory|February 19, 2014
Cardiolipin versus regular antigens in 1949 federal evaluation of serodiagnostic tests for syphilisL O VOSE
Revue Scientifique Et Technique (International Office of Epizootics)|April 1, 1997
Risk analysis in relation to the importation and exportation of animal productsD J Vose
Cancer Immunology, Immunotherapy : CII|January 1, 1984
Activation of lymphocyte anti-tumor responses in man. Towards an understanding of effector cell heterogeneity?B M Vose
Leukemia & Lymphoma|January 1, 1995
CHLVPP therapy for Hodgkin's disease identification of prognostic factorsJ M Vose
Hematology/Oncology Clinics of North America|October 29, 2008
Peripheral T-cell non-Hodgkin's lymphomaJulie M Vose
Investigative Radiology|May 1, 1971
Bone mineral measurement: a question of the reliability of in vitro studiesG P Vose
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2011
Relapsed diffuse large B-cell lymphoma: clinical utility of cell of originJulie M Vose
Pageof 90